Tien Liang BioTech Competitors and Similar CompaniesClear all

Tien Liang BioTech's competitors and similar companies include Laboratorio Reig Jofre, Farmalider, Pharmacare and Microbio.

	Tien Liang BioTech Tien Liang BioTech (天良生物科技企業股份有限公司) is a company that produces and sells pharmaceutical products.	Laboratorio Reig Jofre Laboratorio Reig Jofre researches, develops, manufactures, markets, and sells medicines and nutritional supplements.	Farmalider Farmalider is a pharmaceutical company dedicated to the research, development, and manufacture of pharmaceutical products.	Pharmacare Pharmacare is a company specializing in the development, production, and marketing of pharmaceutical products.	Microbio Microbio (中天生物科技股份有限公司) is a biotechnology company that provides therapeutics development solutions.
Founding Date	Founding Date 1960	Founding Date 1929	Founding Date 1986	Founding Date 1985	Founding Date 2000
Type	Type Public	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare cosmetics drug development pharma supplements	Tags Healthcare cosmetics drug development medical devices pharma supplements	Tags Healthcare biotech cosmetics drug development pharma supplements	Tags Healthcare cosmetics drug development medical devices pharma supplements	Tags Healthcare cosmetics drug development pharma supplements
Locations	Locations HQ	Locations Sant Joan Despí, ES HQ Bruxelles, BE Monaco, MC Warszawa, PL Oeiras, PT Singapore, SG Madrid, ES see more	Locations Alcobendas, ES HQ	Locations HQ	Locations HQ
Employees	Employees N/A	Employees 1,331	Employees 1188% increase	Employees 79	Employees N/A
Financial
Revenue (est.)	Revenue (est.) NT$511.8m (FY, 2025)	Revenue (est.) €331.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) NT$1.7b (FY, 2024)
Cost of goods	Cost of goods NT$213.8m (FY, 2025)	Cost of goods €137.1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods NT$780.2m (FY, 2024)
Gross profit	Gross profit NT$299.1m (FY, 2025)	Gross profit €208.2m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit NT$945.6m (FY, 2024)
Net income	Net income (NT$10.3m) (FY, 2025)	Net income €5m (FY, 2025)	Net income N/A	Net income N/A	Net income (NT$1.3b) (FY, 2024)